Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Conditions:   Acute Leukemia;   Acute Lymphocytic Leukemia;   Acute Myelogenic Leukemia;   Myelodysplastic Syndrome;   Stem Cell Transplantation Interventions:   Procedure: Haploidentical hematopoietic cell transplantation (haploHCT);   Procedure: matched unrelated donor hematopoietic cell transplantation (MUD-HCT) Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials